Prognosis of patients with unilateral extracranial occlusion of the internal carotid artery.

PubWeight™: 0.85‹?›

🔗 View Article (PMID 960171)

Published in Stroke on November 01, 1976

Authors

O Waltimo, M Kaste, R Fogelholm

Articles citing this

Who goes home? Predictive factors in stroke recovery. J Neurol Neurosurg Psychiatry (1985) 1.34

[Long-term prognosis of patients with juvenile infarct. Catamnestic results]. Eur Arch Psychiatry Neurol Sci (1984) 0.75

Articles by these authors

Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet (1998) 14.00

Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS) JAMA (1995) 13.37

Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial. GAIN International Investigators. Lancet (2000) 3.33

Predicting outcome of IV thrombolysis-treated ischemic stroke patients: the DRAGON score. Neurology (2012) 2.86

Patient outcomes from symptomatic intracerebral hemorrhage after stroke thrombolysis. Neurology (2011) 2.22

The treatment of spontaneous intracerebral hemorrhage. A prospective randomized trial of surgical and conservative treatment. J Neurosurg (1989) 2.20

Small-vessel disease relates to poor poststroke survival in a 12-year follow-up. Neurology (2011) 2.19

Pneumonia and urinary tract infection after acute ischaemic stroke: a tertiary analysis of the GAIN International trial. Eur J Neurol (2004) 2.12

Serial measurements of plasma homocysteine levels in early and late phases of ischemic stroke. Eur J Neurol (2007) 2.10

Preceding infection as an important risk factor for ischaemic brain infarction in young and middle aged patients. Br Med J (Clin Res Ed) (1988) 1.90

Two years of Finnish Telestroke: thrombolysis at spokes equal to that at the hub. Neurology (2011) 1.75

Controlled safety study of a hemoglobin-based oxygen carrier, DCLHb, in acute ischemic stroke. Stroke (1999) 1.69

Depression is an independent predictor of poor long-term functional outcome post-stroke. Eur J Neurol (2001) 1.59

A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy. Epilepsy Res (1989) 1.59

Chronic subdural hematoma in adults. Influence of patient's age on symptoms, signs, and thickness of hematoma. J Neurosurg (1975) 1.58

Hemostasis and fibrinolysis activation after subarachnoid hemorrhage. J Neurosurg (1997) 1.57

Dementia three months after stroke. Baseline frequency and effect of different definitions of dementia in the Helsinki Stroke Aging Memory Study (SAM) cohort. Stroke (1997) 1.56

Epidemiology of chronic subdural haematoma. Acta Neurochir (Wien) (1975) 1.55

Neuropsychological sequelae of cardiac arrest. JAMA (1993) 1.52

Adhesion molecule expression in symptomatic and asymptomatic carotid stenosis. Neurology (2003) 1.47

Risk factors for cervical atherosclerosis in patients with transient ischemic attack or minor ischemic stroke. Stroke (1993) 1.42

Quality of life 4 years after stroke. Stroke (1988) 1.42

The transient global amnesia syndrome. An analysis of 35 cases. Eur Neurol (1975) 1.39

Non-cholesterol sterols in serum and endarterectomized carotid arteries after a short-term plant stanol and sterol ester challenge. Nutr Metab Cardiovasc Dis (2010) 1.39

Ethanol intoxication: a risk factor for ischemic brain infarction in adolescents and young adults. Stroke (1982) 1.37

Clinical determinants of poststroke dementia. Stroke (1998) 1.36

Controlled trial of alpha-tocopherol and beta-carotene supplements on stroke incidence and mortality in male smokers. Arterioscler Thromb Vasc Biol (2000) 1.32

Depression after stroke: results of the FINNSTROKE Study. Stroke (1998) 1.32

Endothelial ICAM-1 expression associated with inflammatory cell response in human ischemic stroke. Circulation (1996) 1.30

Early and late posttraumatic seizures in traumatic brain injury rehabilitation patients: brain injury factors causing late seizures and influence of seizures on long-term outcome. Epilepsia (1999) 1.29

The ECASS 3-hour cohort. Secondary analysis of ECASS data by time stratification. ECASS Study Group. European Cooperative Acute Stroke Study. Cerebrovasc Dis (1998) 1.29

Snoring as a risk factor for sleep-related brain infarction. Stroke (1989) 1.29

Diagnosis and management of brain death. Br Med J (1979) 1.28

Evolution of cerebral tumor necrosis factor-alpha production during human ischemic stroke. Stroke (2001) 1.27

White matter hyperintensities as a predictor of neuropsychological deficits post-stroke. J Neurol Neurosurg Psychiatry (2005) 1.24

Thromboembolism in patients with atrial fibrillation. Arch Neurol (1984) 1.22

Toxic effects of ergotamine used for migraine. Headache (1978) 1.21

Comparison of different clinical criteria (DSM-III, ADDTC, ICD-10, NINDS-AIREN, DSM-IV) for the diagnosis of vascular dementia. National Institute of Neurological Disorders and Stroke-Association Internationale pour la Recherche et l'Enseignement en Neurosciences. Stroke (2000) 1.21

Poststroke depression and lesion location revisited. J Neuropsychiatry Clin Neurosci (2004) 1.21

Frequency and clinical determinants of poststroke depression. Stroke (1998) 1.20

Epilepsy after stroke. Epilepsia (1992) 1.20

Stanniocalcin: A molecular guard of neurons during cerebral ischemia. Proc Natl Acad Sci U S A (2000) 1.18

Is chronic brain damage in boxing a hazard of the past? Lancet (1982) 1.17

Cognitive profile of subcortical ischaemic vascular disease. J Neurol Neurosurg Psychiatry (2006) 1.16

Different risk factors for different stroke subtypes: association of blood pressure, cholesterol, and antioxidants. Stroke (1999) 1.15

Dental infections in association with cerebral infarction in young and middle-aged men. J Intern Med (1989) 1.15

Cyclooxygenase-2 is induced globally in infarcted human brain. Ann Neurol (1998) 1.13

The profile of recovery from stroke and factors influencing outcome. Stroke (1985) 1.13

Recent alcohol consumption, cigarette smoking, and cerebral infarction in young adults. Stroke (1995) 1.12

Amyotrophic lateral sclerosis in Middle-Finland: an epidemiological study. Acta Neurol Scand (1983) 1.11

Complement activation in the central nervous system following blood-brain barrier damage in man. Ann Neurol (1996) 1.11

Aspirin dose in stroke prevention: beautiful hypotheses slain by ugly facts. Stroke (1996) 1.11

Post-stroke depression, executive dysfunction and functional outcome. Eur J Neurol (2002) 1.10

Brain creatine kinase in blood after acute brain injury. J Neurol Neurosurg Psychiatry (1975) 1.10

Neurological outcome after out-of-hospital cardiac arrest. Prediction by cerebrospinal fluid enzyme analysis. Arch Neurol (1989) 1.10

Effect of propranolol on essential tremor. Neurology (1976) 1.10

How complex interactions of ischemic brain infarcts, white matter lesions, and atrophy relate to poststroke dementia. Arch Neurol (2000) 1.09

Door to thrombolysis: ER reorganization and reduced delays to acute stroke treatment. Neurology (2006) 1.07

Insomnia in ischemic stroke patients. Cerebrovasc Dis (2002) 1.06

'Iatrogenic' brain stem infarction. A complication of x-ray examination of the cervical spine and following posterior tamponation of the nose. Eur Neurol (1975) 1.05

Outcome of 314 patients with transient ischemic attacks. Stroke (1982) 1.05

Cerebral hemodynamics in a healthy population measured by dynamic susceptibility contrast MR imaging. Acta Radiol (2003) 1.05

Cimetidine-phenytoin interaction: effect on serum phenytoin concentration and antipyrine test. Eur J Clin Pharmacol (1981) 1.05

Serum cortisol and outcome of ischemic brain infarction. J Neurol Sci (1993) 1.03

Magnetic resonance imaging white matter hyperintensities and mechanism of ischemic stroke. Stroke (1999) 1.01

An epidemic due to sulphonamide-resistant group A meningococci in the Helsinki area (Finland). Epidemiological and clinical observations. Scand J Infect Dis (1976) 1.00

Magnetic resonance imaging correlates of depression after ischemic stroke. Arch Gen Psychiatry (2001) 0.99

Prevention of poststroke depression: 1 year randomised placebo controlled double blind trial of mianserin with 6 month follow up after therapy. J Neurol Neurosurg Psychiatry (1999) 0.99

The effect of acute ingestion of a large dose of alcohol on the hemostatic system and its circadian variation. Stroke (2000) 0.99

Subarachnoid haemorrhage: long-term follow-up results of late surgical versus conservative treatment. Br Med J (1978) 0.98

Effects of ethanol on platelet function. Alcohol (1985) 0.97

MRI correlates of executive dysfunction in patients with ischaemic stroke. Eur J Neurol (2003) 0.97

Ischaemic cerebrovascular disease in young adults. 1. Smoking habits, use of oral contraceptives, relative weight, blood pressure and electrocardiographic findings. Acta Neurol Scand (1973) 0.97

Heart type creatine kinase isoenzyme (CK MB) in acute cerebral disorders. Br Heart J (1978) 0.96

Anti-ICAM-1 monoclonal antibody R6.5 (Enlimomab) promotes activation of neutrophils in whole blood. J Immunol (1999) 0.96

Comparison of stroke features and disability in daily life in patients with ischemic stroke aged 55 to 70 and 71 to 85 years. Stroke (1997) 0.96

Epidemiology of central nervous system neoplasms. A regional survey in Central Finland. Acta Neurol Scand (1984) 0.96

Tranexamic acid in subarachnoid hemorrhage. A double-blind study. Stroke (1980) 0.95

Silent brain infarcts, leukoaraiosis, and long-term prognosis in young ischemic stroke patients. Neurology (2011) 0.95

Alcohol consumption and stroke incidence in male smokers. Circulation (1999) 0.94

Brain-type creatine kinase isoenzyme. Occurrence in serum in acute cerebral disorders. Arch Neurol (1977) 0.94

Snoring, sleep apnea syndrome, and stroke. Neurology (1992) 0.94

Diabetes mellitus and ischemic stroke in the young: clinical features and long-term prognosis. Neurology (2011) 0.94

Increase in serum cholesterol during phenytoin treatment. Br Med J (1975) 0.94

Economic burden of stroke and the evaluation of new therapies. Public Health (1998) 0.93

Late prognosis of severe brain injury in children. Dev Med Child Neurol (1974) 0.93

Predicting late outcome for patients with traumatic brain injury referred to a rehabilitation programme: a study of 508 Finnish patients 5 years or more after injury. Brain Inj (1998) 0.93

Acute surgery for intracerebral haematomas caused by rupture of an intracranial arterial aneurysm. A prospective randomized study. Acta Neurochir (Wien) (1988) 0.93

Marchiafava-Bignami disease: two cases with favourable outcome. Eur J Neurol (2001) 0.93

Cognitive impairment predicts poststroke death in long-term follow-up. J Neurol Neurosurg Psychiatry (2009) 0.92

Regular light-to-moderate intake of alcohol and the risk of ischemic stroke. Is there a beneficial effect? Stroke (1993) 0.92

Ethanol intoxication: a risk factor for ischemic brain infarction. Stroke (1984) 0.91

Age related white matter changes predict stroke death in long term follow-up. J Neurol Neurosurg Psychiatry (2009) 0.91

Elevation of high-density lipoprotein in epileptic patients treated with phenytoin. Acta Med Scand (1978) 0.91

Cerebral convulsion after enfluran anaesthesia and occupational exposure to tetrahydrofuran. J Neurol Neurosurg Psychiatry (1984) 0.90

Nimodipine after resuscitation from out-of-hospital ventricular fibrillation. A placebo-controlled, double-blind, randomized trial. JAMA (1990) 0.90

Post-stroke depression and functional recovery in a population-based stroke register. The Finnstroke study. Eur J Neurol (1999) 0.90

Does alcohol intoxication precipitate aneurysmal subarachnoid haemorrhage? J Neurol Neurosurg Psychiatry (1981) 0.90